Taishō

DGAP-News: Jupiter Wellness's Booster Drug Has Potential To Increase Hair Loss Treatments' Efficacy By Enhancing Crucial Enzyme Enrichment Capacity by 7x

Retrieved on: 
Tuesday, September 13, 2022

Women sometimes equate a bad hair day with a bad day overall, and the condition of a womans hair can impact confidence.

Key Points: 
  • Women sometimes equate a bad hair day with a bad day overall, and the condition of a womans hair can impact confidence.
  • Hair loss and its treatment have found a prominent place in discussions relating to hair care.
  • In the U.S., well-known products for the treatment of hair loss include Johnson & Johnsons (NYSE: JNJ) Rogaine, Vegamour GRO hair serum, and Nutrafol hair growth supplements.
  • Jupiter Wellness may have a lucrative addition to hair loss treatments with current minoxidil distributors becoming significant distributors in the future.

Global Rheumatoid Arthritis (RA) Pipeline Market Research Report 2022: Comprehensive Insights About 120+ Companies and 120+ Pipeline Drugs - ResearchAndMarkets.com

Retrieved on: 
Wednesday, May 25, 2022

This "Rheumatoid Arthritis- Pipeline Insight, 2022" report provides comprehensive insights about 120+ companies and 120+ pipeline drugs in Rheumatoid Arthritis pipeline landscape.

Key Points: 
  • This "Rheumatoid Arthritis- Pipeline Insight, 2022" report provides comprehensive insights about 120+ companies and 120+ pipeline drugs in Rheumatoid Arthritis pipeline landscape.
  • A detailed picture of the Rheumatoid Arthritis pipeline landscape is provided which includes the disease overview and Rheumatoid Arthritis treatment guidelines.
  • The assessment part of the report embraces, in depth Rheumatoid Arthritis commercial assessment and clinical assessment of the pipeline products under development.
  • The companies and academics are working to assess challenges and seek opportunities that could influence Rheumatoid Arthritis R&D.

Rheumatoid Arthritis (RA) Pipeline Landscape Market Report 2021: Comprehensive Insights About 100+ Companies & Respective Pipeline Drugs - ResearchAndMarkets.com

Retrieved on: 
Thursday, August 5, 2021

This Rheumatoid Arthritis (RA) - Pipeline Insight, 2021 provides comprehensive insights about 100+ companies and 100+ pipeline drugs in Rheumatoid Arthritis (RA) pipeline landscape.

Key Points: 
  • This Rheumatoid Arthritis (RA) - Pipeline Insight, 2021 provides comprehensive insights about 100+ companies and 100+ pipeline drugs in Rheumatoid Arthritis (RA) pipeline landscape.
  • The companies and academics are working to assess challenges and seek opportunities that could influence Rheumatoid Arthritis (RA) R&D.
  • This segment of the report provides insights about the different Rheumatoid Arthritis (RA) drugs segregated based on following parameters that define the scope of the report, such as:
    There are approx.
  • Rheumatoid Arthritis (RA) pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration.